Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 24, 2023 11:17 ET | Source: Hagens Berman Sobol Shapiro LLP

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Mersana Therapeutics (MRSN) Investors with Substantial Losses to Contact Firm’s Attorneys, Firm Investigating Possible Securities Law Violations

SAN FRANCISCO, July 24, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Mersana Therapeutics, Inc. (NASDAQ: MRSN) investors who suffered substantial losses to submit your losses now. Visit:...
July 03, 2023 15:50 ET | Source: Hagens Berman Sobol Shapiro LLP

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Mersana Therapeutics (MRSN) Investors with Substantial Losses to Contact Firm’s Attorneys, Firm Investigating Possible Securities Law Violations

SAN FRANCISCO, July 03, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Mersana Therapeutics, Inc. (NASDAQ: MRSN) investors who suffered substantial losses to submit your losses now. Visit:...
June 26, 2023 14:15 ET | Source: Hagens Berman Sobol Shapiro LLP

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Mersana Therapeutics (MRSN) Investors with Substantial Losses to Contact Firm’s Attorneys, Firm Investigating Possible Securities Law Violations

SAN FRANCISCO, June 26, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Mersana Therapeutics, Inc. (NASDAQ: MRSN) investors who suffered substantial losses to submit your losses now. Visit:...
June 23, 2023 16:30 ET | Source: Kaplan Fox & Kilsheimer LLP

Mersana Therapeutics Shareholder Alert: Kaplan Fox Launches Investigation into Mersana Therapeutics, Inc. for Potential Securities Violations

NEW YORK, June 23, 2023 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating potential claims on behalf of investors who purchased Mersana Therapeutics, Inc....
June 20, 2023 14:55 ET | Source: Hagens Berman Sobol Shapiro LLP

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Mersana Therapeutics (MRSN) Investors with Substantial Losses to Contact Firm’s Attorneys, Firm Investigating Possible Securities Law Violations

SAN FRANCISCO, June 20, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Mersana Therapeutics, Inc. (NASDAQ: MRSN) investors who suffered substantial losses to submit your losses now. Visit:...